Gujarat Inject (Kerala) Ltd.

9.95 -0.48 ▼-4.6%

28 March 2024, 04:01:00 PM
Volume: 100

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gujaratinject.in
Market Cap 11.79 Cr.
Enterprise Value(EV) 12.40 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.04 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 240.67 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 4.98 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.10 Calculated using Price: 10.43
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.13 Cr. 11,306,500 Shares
FaceValue 10
About Gujarat Inject (Kerala) Ltd.
Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala.

Gujarat Inject (Kerala) Ltd. Delivery

Delivered Qty
Traded Qty

Gujarat Inject (Kerala) Ltd. Performance

1 Day
-4.60%
1 Week
-18.44%
1 Month
-26.41%
3 Month
-23.46%
6 Month
+10.19%
1 Year
+31.96%
2 Year
5 Year
10 Year

Gujarat Inject (Kerala) Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 0 0 0 0 0 0 0 0
Return on Capital Employed (%) 0 0 0 0 0 0 0 0 0
Return on Assets (%) -1.84 1373.74 6.93 -102.49 -30.2 1.57 -664.44 5.37 22.31

Gujarat Inject (Kerala) Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -3 -1 -1 -1 -1 -1 -1 -1 -1 -1
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 3 1 0 0 0 0 0 1 1 1
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 0 0
Non Curr. Assets 0 0 0
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 0 0

Gujarat Inject (Kerala) Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 2 0 0 0 0
Other Income 0 0 0 0 0 0 0
Total Income 0 2 0 0 0 0 0 1 0
Total Expenditure 0 -2 0 0 0 0 0 -1 0
PBIDT 0 0 0 0 0 0
Interest
Depreciation
Taxation 0 0
Exceptional Items 2
PAT 2 0 0 0 0 0 0
Adjusted EPS 0 5 0 0 0 0 0 0

Gujarat Inject (Kerala) Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0
Cash Fr. Inv.
Cash Fr. Finan. 0
Net Change 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Gujarat Inject (Kerala) Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Gujarat Inject (Kerala) Ltd. Announcements

Wed, 27 Mar 2024
Closure of Trading Window
Closure of Trading Window for Insiders of the Company
Sat, 23 Mar 2024
Announcement under Regulation 30 (LODR)-Allotment
Allotment of 2907500 equity shares pursuant to excercise of warrants allotted on preferential basis
Thu, 21 Mar 2024
Announcement under Regulation 30 (LODR)-Preferential Issue
Revised outcome for allotment of warrants of Face Value of Rs. 10.00 on preferential issue basis

Gujarat Inject (Kerala) Ltd. Technical Scans

Wed, 27 Mar 2024
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low

Gujarat Inject (Kerala) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 385,837.06 1,620.50 +0.8%
Cipla Ltd. 118,376.16 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 100,885.01 6,171.85 +2.0%
Zydus Lifesciences Ltd. 100,583.15 1,007.35 +0.8%
Mankind Pharma Ltd. 93,457.28 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 89,582.15 6,347.35 +1.9%
Divi's Laboratories Ltd. 89,323.54 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.32 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 31.92 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.82 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 54.11 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.49 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 64.59 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.18 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.57 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.75 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.20 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.52 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.26 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 6.85 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Gujarat Inject (Kerala) Ltd. FAQ's

What is Guj. Inject (Kerala) share price?

Can I buy Guj. Inject (Kerala) shares now?

What is the Market Cap of Guj. Inject (Kerala)?

What are the key metrics to analyse Guj. Inject (Kerala)?

What is the 52 Week High and Low of Guj. Inject (Kerala)?

What is the trend of Guj. Inject (Kerala) share price?